Skip to main content

Table 1 Description of the different groups and their activation protocol

From: Mechanisms of leukocyte distribution during sepsis: an experimental study on the interdependence of cell activation, shear stress and endothelial injury

Group

Activation

Description

HUVEC-/PMN-

HUVEC 0 ng/ml LPS

Control (non-inflamed tissue)

 

+ PMN 0 ng/ml LPS

 

HUVEC++/PMN-

HUVEC 100 ng/ml LPS

Maximal local inflammation

 

+ PMN 0 ng/ml LPS

 

HUVEC++/PMN ++

HUVEC 100 ng/ml LPS

Maximal systemical inflammation in the hyper-inflammatory stage of sepsis

 

+ PMN 100 ng/ml LPS

 

HUVEC+/PMN-

HUVEC 10 ng/ml LPS

Submaximal local inflammation

 

+ PMN 0 ng/ml LPS

 

HUVEC+/PMN +

HUVEC 10 ng/ml LPS

Submaximal systemical inflammation in the hypo-inflammatory stage of sepsis

 

+ PMN 10 ng/ml LPS

 

HUVEC++/PMN++/PLT

HUVEC 100 ng/ml LPS

Maximal systemical inflammation and endothelial damage in the hyper-inflammatory stage of sepsis

 

+ PMN 100 ng/ml LPS

 

HUVEC+/PMN+/PLT

HUVEC 10 ng/ml LPS

Submaximal systemical inflammation and endothelial damage in the hypo-inflammatory stage of sepsis

 

+ PMN 10 ng/ml LPS

 
  1. HUVEC, human umbilical venous endothelial cells; PMN, polymorphonuclear neutrophils; PLT, platelets; LPS, lipopolysaccharide.